跳至主要内容
临床试验/NCT05525871
NCT05525871已完成不适用

Experimental Study to Evaluate the Effects of Effects of a Sports Supplement Based on Nitrates and Citrulline Malate on Performance in Professional Soccer Players

Universidad Católica San Antonio de Murcia2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Aerobic and anaerobic thresholds - VO2max

研究概览

简要总结

Randomized, single-center, parallel, team-stratified, stratified experimental study to evaluate the efficacy of a high sports supplement in improving high-intensity intermittent exercise performance in professional female soccer players.

详细描述

Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned).

The product to be consumed will be Nitrates and Citrulline Malate. Participants will consume the product for 30 days. The intake should be done two hours before each training session and the same dose will be consumed.

The women's soccer players will perform a stress test with gas analysis to measure performance, as well as a Wingate test without consumption of the products. Five days later, the players will perform the Yo-Yo IR1 test in the field and will repeat the same tests performed at the beginning of the test after product consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Present at the time of signing the informed consent at the age between 18 and 40 years.
  • Healthy subjects without any chronic disease.
  • Volunteers capable of understanding the clinical study, willing to give their written informed. consent and comply with the procedures and requirements of the study. and requirements of the study.

排除标准

  • Players who change teams during the experimental study.
  • Smoking subjects.
  • Subjects using mouthwashes during the study.
  • Subjects with a history of drug, alcohol or other substance abuse or other factors that limit their ability to cooperate during the study. factors that limit their ability to cooperate during the study.
  • Subjects whose status makes them ineligible for the study, at the discretion of the investigator discretion of the investigator.

结局指标

主要结局

Aerobic and anaerobic thresholds - VO2max

时间窗: Change in initial maximal oxygen consumption at 30 days

Measured with a gas analyzer

Fatigue in jumping

时间窗: Change in initial jump fatigue at 30 days

Measured with a contact platform

Anaerobic capacity

时间窗: Change in baseline anaerobic capacity at 30 days

Measured with a Monark cycloergometer

次要结局

  • Microcapillary blood(It will be measured on two different occasions. Day one and 30 days later.)
  • Lactate(It will be measured on two different occasions. One on the first day (without intake of product ) and 30 days later, the same measurements but after having consumed the product)
  • Safety variables(It will be measured on two different occasions. Day one and 30 days later.)

研究者

发起方
Universidad Católica San Antonio de Murcia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco Javier López Román

Principal Investigator

Universidad Católica San Antonio de Murcia

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Pelvic physiotherapy after surgical treatment for cervical cancer1. Early stage cervical cancer<br />2. pelvic physiotherapy<br />3. pelvic floor related quality of life<br />4. micturition<br />5. defecation<br />6. sexual problems<br />(Vroeg stadium cervixcarcinoom, bekken fysiotherapie, bekkenbodem gerelateerde kwaliteit van leven, mictie-/defecatie- en seksuele problemen).
NL-OMON26289Dr J.P. Roovers, gynaecologist72
进行中(未招募)
不适用
A multi-centre randomised study to evaluate the efficacy of Betaferon-interferon-beta-1b (IFNB-1B) 500 mcg therapy in the induction of tolerance to IFNB in MS patients with neutralising antibodies (NAbs) to IFNB-1a (Rebif) - Betaferon NaB Anergy StudyMultiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown aetiology. It is the commonest cause of disability in young adults. The prevalence in the UK is approximately 125/100,000 of the population with an annual incidence of 6/100,000. Approximately 80,000 individuals are affected with MS in the UK.
EUCTR2005-005751-18-GBCL Biomedicine R&D Unit100
招募中
2 期
Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHNHead and Neck NeoplasmsRecurrent DiseaseMetastatic Cancer
NCT05260671Eye & ENT Hospital of Fudan University48
已完成
Unknown
Evaluation of the effects of cinchona supplementation on nutritional status and body composition in overweight/obese adults undergoing a hypocaloric dietOverweight/obese adult subjectsNutritional, Metabolic, Endocrine
ISRCTN13055163niversity of Naples Federico II60
尚未招募
不适用
Multicenter randamized study for evaluating the effect of dantrolene aganst heart failure and arrhythmiaheart failure
JPRN-UMIN000022756Yamaguchi University Graduate School of Medicine100